Beth Karlan, MD

Cedars-Sinai, UCLA

KarlanDr. Karlan is Director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and Director of the Gilda Radner Hereditary Cancer Program. She holds the Board of Governors Chair in Gynecologic Oncology. Dr. Karlan is also Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Board certified in Obstetrics and Gynecology and in Gynecologic Oncology, Dr. Karlan has been awarded research grants from the Department of Defense, National Institutes of Health and the American Cancer Society. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. Dr. Karlan has written over 200 peer reviewed articles, and is Editor-in-Chief of the publications Gynecologic Oncology and Gynecologic Oncology Case Reports.

Dr. Karlan served as President of SGO in 2005-2006 and has held leadership positions with the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology, and the Board of Governors of the American College of Surgeons. Dr. Karlan holds an Early Detection Professorship with the American Cancer Society.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.